A new review maps how cancer-associated fibroblasts exclude immune cells from osteosarcoma tumors and outlines the ...

Researchers report that the serotonin receptor HTR1D drives osteosarcoma metastasis and doxorubicin resistance through a ...

Researchers show that editing activity of ADAR2 abolishes its proliferative effect on osteosarcoma cells and triggers terminal differentiation, indicating that ADAR2 acts as a tumor suppressor in ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...

An experimental cancer drug was found to slow the growth of canine and human osteosarcoma cells in laboratory tests conducted at The Ohio State University College of Veterinary Medicine, according to ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a ...

Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma. There ...

The complex tumor microenvironment (TME) in osteosarcoma is emerging as a critical factor in disease progression and treatment resistance. Recent insights highlight the intricate interplay between ...

FAYETTEVILLE, GA, UNITED STATES, July 3, 2026 /EINPresswire.com/ — Researchers have engineered a multifunctional gallium-doped bioactive glass that selectively ...

Zn, might be useful against bone cancer in dogs, but more studies will need to be completed to confirm its effectiveness. Check out the information ...